Journals / Uludağ Üniversitesi Veteriner Fakültesi Dergisi / 2018 / Cilt: 37 - Sayı: 2

Effect Of Tamoxifen Treatment On The Epidermal Growth Factor Receptor Expression In The Mouse Ovarian Tissue

Pages
119–125
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, it was observed that the administered doses of TAM have not significant influence on EGFR expression.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The objective of this study was to investigate the effect of Tamoxifen (TAM) treatment on epidermal growth factor receptor (EGFR) expression in the pubertal mice ovary.
📊
Key Findings & Data:In this study, 80 female mice (8 week-old) were used.
💡
Conclusion & Impact:As a result, it was observed that the administered doses of TAM have not significant influence on EGFR expression.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

The objective of this study was to investigate the effect of Tamoxifen (TAM) treatment on epidermal growth factor receptor (EGFR) expression in the pubertal mice ovary. In this study, 80 female mice (8 week-old) were used. Animals divided four groups; non-injected (control A), injected with TAM’s vehicle solution (control B). The mice in groups TAM 0.5 and TAM 1.5 were treated with TAM at a dose 0.5 and 1.5 mg/mouse/day respectively. TAM was dissolved with 10% ethanol: 90% corn oil. Mice were given daily subcutaneously injections for 5 days. Ovarian sections were immunostained with EGFR antibody and trichrome staining for examine the general structure. We observed that follicular atresia was increased, follicular cysts were formed in stroma, and interstitial cells were increased with TAM dose treatment. In the present study, there were no significant differences in the EGFR expression in mouse ovary of all groups. EGFR expression was not determined in the granulosa cells. While strong EGFR immunoreaction was observed in the interstitial cells and oocyte cytoplasm, weak EGFR immunoreactions was observed in theca cells of follicles. As a result, it was observed that the administered doses of TAM have not significant influence on EGFR expression.

🔖

Cite This Article

ASMAZ, E. D., ZIK, B. (2018). Effect Of Tamoxifen Treatment On The Epidermal Growth Factor Receptor Expression In The Mouse Ovarian Tissue. Uludağ Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 37 - Sayı: 2, 119–125. https://ajindex.com/articles/326270

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Arteaga CL. Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist, 4: 31-39, 2002.
  2. Ashkenazi H, Cao X, Motola S, Popliker M, Conti M, Tsafriri A. Epidermal growth factor family members: endogenous mediators of the ovulatory response. Endocrinology, 146: 77-84, 2005.
  3. Atalay G, Cardoso F, Awada A, Piccart MJ. Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer. Ann Oncol, 14: 1346-1363, 2003.
  4. Ayyagari RR, Khan-Dawood FS. Human corpus luteum: presence of epidermal growth factor receptors and its binding characteristics. Am J Obstet Gynecol, 150: 942-946, 1987.
  5. Bernstein L, Deapen D, Cerhan JR. Tamoksifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst, 91: 1654–1662, 1999.
  6. Blumenfeld Z, Dann E, Avivi R, Epelbaum R, Rowe JM. Fertility after treatment for hodgkin’s disease. Ann Oncol, 13: 138-147, 2002.
  7. Clarke M, Cillins R, Davies C. Tamoksifen for early breast cancer: an overview of the randomized trials. Lancet, 351: 1451-1467, 1998. Crossman GA. Modification of Mallory’s Connective Tissue stain with a discussion of the principles ınvolved. Anat Rec, 69(1): 33-38, 1937.
  8. Das K, Stout LE, Hensleigh HC, Tagatz GE, Phipps WR, Leung BS. Direct positive effect of epidermal growth factor on the cytoplasmic maturation of mouse and human oocytes. Fertil Steril, 55: 1000–1004, 1991. Dowsett M1, Cuzick J, Wale C, Forbes J, Mallon EA, Salter J, Quinn E, Dunbier A, Baum M, Buzdar A, Howell A, Bugarini R, Baehner FL. Shak S. Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. J Clin Oncol, 28(11): 1829-1834, 2010.
  9. Duncan MD, Korman LY, Bass BL. Epidermal growth factor primes intestinal epithelial cells for proliferative effect of insulin-like growth factor I. Dig Dis Sci, 39: 2197-201, 1994.
  10. Ekambaram G, Kumar S, Kumar S, Joseph LD. Comparative study on the estimation of estrous cycle in mice by visual and vaginal lavage method. J Clin Diagn Res,11(1): AC05- AC07, 2017.
  11. Ergin K, Gursoy E, Bağımoğlu KY, Baġaloğlu H, Seyrek K. Immunohistochemical detection of insulin-like growth factor-I, transforming growth factor-b2, basic fibroblast growth factor and epidermal growth factor-receptor expression in developing rat ovary. Cytokine, 43: 209-214, 2008.
  12. Feng P, Knecht M